• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR; ANTI-TSHR IMMUNOASSAY Back to Search Results
Model Number ANTI-TSHR
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/01/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for one patient sample tested with elecsys ft3 iii, the elecsys ft4 iii assay, the elecsys tsh assay, and the elecsys anti-tshr immunoassay when tested on the customer's cobas 8000 e 801 module and a second e 801 module used for investigation.The sample also had discrepant results for the elecsys ft4 ii assay when tested on the e 801 module used for investigation.Incorrect results were reported outside of the laboratory.This medwatch will apply to the anti-tshr assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay, refer to the medwatch with patient identifier (b)(6) for information related to the ft4 iii assay, refer to the medwatch with patient identifier (b)(6) for information related to the ft4 ii assay, and refer to the medwatch with patient identifier (b)(6) for information related to the tsh assay.The sample was collected from the patient on (b)(6) 2019.The sample was tested on the customer's e 801 analyzer and with the wako accuraseed method on (b)(6) 2019.The sample was repeated for tsh, ft4, and ft3 using the architect method and repeated for anti-tshr using the yamasa method.The sample was provided for investigation where it was tested for tsh, ft3, ft4 iii, and ft4 ii on the second e 801 module on (b)(6) 2019.The sample was also tested for anti-tshr on the second e 801 module on (b)(6) 2019.The serial number of the customer's e 801 analyzer is (b)(4).The serial number of the e 801 analyzer used for investigation is (b)(4).Anti-tshr reagent lot number 408206, with an expiration date of june 2020 was used on this analyzer.
 
Manufacturer Narrative
The investigation determined the patient sample contained an interferent to the streptavidin component of the anti-tshr assay.This limitation is covered in product labeling.Per labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-TSHR, ANTIBODIES TO TSH RECEPTOR
Type of Device
ANTI-TSHR IMMUNOASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9213677
MDR Text Key217165670
Report Number1823260-2019-03788
Device Sequence Number1
Product Code JZO
Combination Product (y/n)N
PMA/PMN Number
K080092
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberANTI-TSHR
Device Catalogue Number07026951190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/01/2019
Initial Date FDA Received10/21/2019
Supplement Dates Manufacturer Received10/01/2019
Supplement Dates FDA Received12/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-